Jacobs Levy Equity Management’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$395K Sell
2025
Q1
$459K Buy
2024
Q4
$1.59M Buy
2024
Q3
$1.88M Buy
2024
Q2
$976K Sell
2024
Q1
$3.63M Sell
2023
Q4
$2.16M Buy
2023
Q2
Sell
2023
Q1
$271K Sell
2022
Q4
$2.95M Buy
2022
Q3
$2.73M Buy
2019
Q4
Sell
2019
Q3
$242K Sell
2019
Q2
$676K Buy
2019
Q1
Sell
2018
Q4
$158K Buy